Disruption of PrPC/P-gp complex has profound effects on tumor survival and aggressiveness, since it markedly reduces the anti-apoptotic activity, while promoting the reversal of PrPC-mediated drug resistance in MDR breast cancer cells [135]. This evidence concerns the gene PGP and breast cancer.